Bio Sequence

Searching for Modified Sequences: The Best Biological Databases to Consider

13 September 2023
2 min read

Sequence modification is an important attribute of a sequence, particularly in the field of small nucleic acids. Sequence modifications, including fluorescence labeling, glycosylation, phosphorylation, and others, can enhance the functionality of a sequence, making them highly meaningful. In the Patsnap Bio Sequence Database, you can search for modified sequences. Firstly, input an RNA sequence and perform a BLAST search.

You can quickly and accurately obtain similar sequences of your query in patents. On the search results page, you can filter the results based on the presence of modifications to find the modified sequences. By viewing the details, you can explore the specific modifications present in the sequences of interest.

图形用户界面, 文本, 应用程序, 电子邮件, 网站

描述已自动生成

In the sequence modification display interface, you can easily and conveniently see the modifications of a sequence through a graphical interface. It provides a clear visualization of the modifications present in the sequence. Additionally, if you are interested in patents related to modified sequences, you can explore the patents associated with the modified sequences. This can be highly beneficial for research and development users, as they can read and analyze these patents for further insights.

图形用户界面, 文本, 应用程序

描述已自动生成

Patsnap Bio is the largest sequence search platform for the Patsnap database. It integrates AI and human-curated data for the comprehensive processing of protein and nucleotide sequence data from global patents, biological journals, and public repositories. Key biological sequences are manually annotated, highlighting structural modifications to provide the most accurate sequence information and enhance sequence retrieval efficiency.

Free registration is currently available to utilize the Bio biological sequence database: https://bio-patsnap-com.libproxy1.nus.edu.sg. Act now to expedite your sequence search tasks.

Seladelpar from CymaBay Reaches Significant Statistical Levels for primary and key Secondary endpoints in the RESPONSE Phase 3 Trial
Latest Hotspot
4 min read
Seladelpar from CymaBay Reaches Significant Statistical Levels for primary and key Secondary endpoints in the RESPONSE Phase 3 Trial
13 September 2023
Biotech firm CymaBay Therapeutics, Inc. revealed positive Phase 3 trial outcomes for seladelpar, a novel treatment for liver and chronic diseases, including primary biliary cholangitis. Meeting all primary and key secondary endpoints.
Read →
JAK1 Inhibitor - A rising star of small molecule targeted drugs in the field of autoimmunity
JAK1 Inhibitor - A rising star of small molecule targeted drugs in the field of autoimmunity
13 September 2023
In autoimmune diseases, JAK inhibitors can mediate immune suppression and inhibit the increase of serum pro-inflammatory cytokines.
Read →
Adrenomed presents novel results for their precision medicine therapy with enibarcimab for septic shock
Latest Hotspot
3 min read
Adrenomed presents novel results for their precision medicine therapy with enibarcimab for septic shock
13 September 2023
Adrenomed AG has disclosed recent discoveries regarding the biomarker-directed therapy of septic shock with enibarcimab.
Read →
A Comprehensive Review of Febuxostat's R&D Innovations
Drug Insights
4 min read
A Comprehensive Review of Febuxostat's R&D Innovations
13 September 2023
This article summarized the latest R&D progress of Febuxostat, the Mechanism of Action for Febuxostat, and the drug target R&D trends for Febuxostat.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.